Subtype
Genitourinary System Carcinoma
CI-CAN-00000925Explore in graph →
1,501 active trials44 approved drugs143 evidence items
- NCIt
- C164141
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000925Explore in graph →
Clinical trials
4,919 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (758)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04520464 | Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro)(Xyto-Ro) | unknown | N/A | 444 | Hospital General de México Dr. Eduardo LiceagaOTHER_GOV | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04504110 | 68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings | unknown | Phase 2 | 30 | Peking Union Medical College HospitalOTHER | 1 |
| Aug 10, 2020 |
| clinicaltrials |
| NCT04486937 | SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation(mCRPC) | unknown | Phase 1 / Phase 2 | 90 | Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY | 0 | Jul 27, 2020 | clinicaltrials |
| NCT03934164 | Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO(MAESTRO) | unknown | — | 600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer(PERSEUS1) | unknown | Phase 2 | 100 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT03987698 | Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma | unknown | Phase 2 | 90 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03371693 | Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer(HIPECOV) | unknown | Phase 3 | 112 | Zhongnan HospitalOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT02691975 | A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 197 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 13, 2020 | clinicaltrials |
| NCT04146831 | Sintilimab in FH-deficient Renal Cell Carcinoma | unknown | Phase 2 | 37 | West China HospitalOTHER | 0 | May 12, 2020 | clinicaltrials |
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)(POUT) | unknown | Phase 3 | 261 | Institute of Cancer Research, United KingdomOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT03259477 | RFR Change of Precise Segmental Versus Complete Renal Arterial Clamping During LPN for Clinical T1 RCC | unknown | N/A | 100 | Xuanwu Hospital, BeijingOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | unknown | Phase 3 | 290 | RenJi HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT03078400 | Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer | unknown | Phase 1 | 14 | Splash Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 18, 2020 | clinicaltrials |
| NCT04295967 | Vasculogenic Mimicry in Urothelial Carcinoma | unknown | — | 70 | Assiut UniversityOTHER | 0 | Mar 5, 2020 | clinicaltrials |
| NCT03349463 | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | unknown | Phase 4 | 30 | Bital Savir-BaruchOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT03150121 | Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage(BEDOCA) | unknown | N/A | 500 | Sheba Medical CenterOTHER_GOV | 1 | Feb 26, 2020 | clinicaltrials |
| NCT04268368 | Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors(ICI-DISCOVER) | unknown | — | 200 | Università Politecnica delle MarcheOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT04264936 | A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer | unknown | Phase 1 / Phase 2 | 36 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04261465 | NUVOLA TRIAL Open-label Multicentre Study(NUVOLA) | unknown | Phase 2 | 35 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 7, 2020 | clinicaltrials |
| NCT02928692 | Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium(MAPOCD) | unknown | Phase 3 | 750 | RenJi HospitalOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT04224467 | The Application of Real-Time Near-infrared Imaging in Gynecological Surgery | unknown | N/A | 500 | Chen ChunlinOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT04225910 | Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer | unknown | Early Phase 1 | 20 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT04223063 | Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study | unknown | N/A | 20 | Ross MasonOTHER | 0 | Jan 10, 2020 | clinicaltrials |
| NCT04220398 | Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer | unknown | N/A | 475 | RenJi HospitalOTHER | 0 | Jan 7, 2020 | clinicaltrials |
| NCT04213664 | Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.(LMR) | unknown | — | 4,666 | Corporacion Parc TauliOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT04191252 | Genetic Mutation in Epithelial Ovarian Cancer | unknown | — | 500 | Lei LiOTHER | 1 | Dec 20, 2019 | clinicaltrials |
| NCT03638206 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | unknown | Phase 1 / Phase 2 | 73 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Dec 11, 2019 | clinicaltrials |
| NCT04190667 | Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer | unknown | — | 1,300 | Lei LiOTHER | 1 | Dec 10, 2019 | clinicaltrials |
| NCT04188587 | 177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer | unknown | Phase 2 | 30 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 6, 2019 | clinicaltrials |
| NCT03373058 | Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery(EHTASEOCCS) | unknown | Phase 3 | 310 | Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT04148885 | A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 44 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 4, 2019 | clinicaltrials |
| NCT03220932 | Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer(HIPOVA-01) | unknown | Phase 3 | 132 | Hospices Civils de LyonOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT04129606 | Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy(TURBT-BP) | unknown | N/A | 300 | Abdelwahab HashemOTHER | 1 | Oct 17, 2019 | clinicaltrials |
| NCT03210298 | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)(PIPACRegis) | unknown | — | 1,000 | Sabine RhodeOTHER | 13 | Oct 8, 2019 | clinicaltrials |
| NCT04101760 | Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer | unknown | Phase 3 | 200 | Lei LiOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT03302884 | Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma(CIDOC) | unknown | N/A | 150 | Institut Paoli-CalmettesOTHER | 1 | Sep 26, 2019 | clinicaltrials |
| NCT03694912 | Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers | unknown | — | 426 | Yonsei UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03592199 | Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib(SuAx) | unknown | Phase 2 | 7 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT04060537 | Identification of Novel Biomarkers of Response to Systemic Treatments in Renal Cell Cancer(ARTIST_RCC) | unknown | — | 12 | CCTU- Cancer ThemeOTHER | 0 | Aug 19, 2019 | clinicaltrials |
| NCT01682772 | TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer(TOPARP) | unknown | Phase 2 | 148 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 15, 2019 | clinicaltrials |
| NCT03451812 | Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer(PCAPETMR) | unknown | — | 120 | Chang Gung Memorial HospitalOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04049344 | Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT04001023 | Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia(OVANOX) | unknown | N/A | 40 | Turku University HospitalOTHER_GOV | 1 | Aug 7, 2019 | clinicaltrials |
| NCT04031378 | Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer | unknown | Phase 2 | 100 | Fundacao ChampalimaudOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT04029909 | A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | unknown | Phase 1 | 12 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03255135 | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | unknown | N/A | 130 | Hospital de Transplante Doutor Euryclides de Jesus ZerbiniOTHER | 1 | Jun 27, 2019 | clinicaltrials |
| NCT03998371 | Application of UCAD for Diagnosing Urothelial Carcinoma. | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT03996993 | Defining Recurrent Disease With Axumin™ | unknown | — | 20 | Cancer Center of IrvineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03975127 | Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme? | unknown | N/A | 50,000 | NHS Greater Glasgow and ClydeOTHER | 0 | Jun 5, 2019 | clinicaltrials |
| NCT03960788 | Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | unknown | Early Phase 1 | 50 | University of CincinnatiOTHER | 1 | May 23, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Aug 20, 2020source: clinicaltrials